Clinical Trial Update: ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Ziltivekimab to placebo in patients with acute myocardial infarction; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Ziltivekimab

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Cardiovascular Risk, Acute Myocardial Infarction (AMI) | Phase 3 | Status: RECRUITING